Paracel Explorer

Dernière publication·Juillet 2026

Livostin

Levocabastinum — gtt opht 0.5 mg/ml

JNTL Consumer Health II (Switzerland) GmbH

Swissmedic50496

Dossier15977

Remboursement

QP 10%

Modifications (5)